| Dr Liban Farah, MD | |
|
1100 Bergslien St, Baldwin, WI 54002-2600 | |
| (715) 684-1111 | |
| (715) 694-1119 |
| Full Name | Dr Liban Farah |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 35 Years |
| Location | 1100 Bergslien St, Baldwin, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962796862 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 56541 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Western Wisconsin Health | Baldwin, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Francis Regional Medical Center | 7214821909 | 88 |
| Baldwin Area Medical Center Inc | 7911800586 | 66 |
News Archive
Shortages of medical supplies such as ventilators, face shields and masks has been a recurring problem during the COVID-19 pandemic and production has struggled to keep up.
A new study, published on the bioRxiv* preprint server, has focused on public clonotypes, i.e., clones found in multiple individuals, for the development of a novel reverse epitope discovery technique. This technique holds greater potential for population-wide applications.
Brown was diagnosed with COPD and emphysema, the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals. Like most COPD patients, Brown was given medication but told there was no cure. He was 58 years old.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced data with the EndoBarrier Gastrointestinal Liner at 12 months showing significant weight loss and cardiovascular and metabolic improvements in obese patients.
› Verified 6 days ago
| Entity Name | Centracare Health System - Melrose |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720045073 PECOS PAC ID: 1658270368 Enrollment ID: O20031231000690 |
News Archive
Shortages of medical supplies such as ventilators, face shields and masks has been a recurring problem during the COVID-19 pandemic and production has struggled to keep up.
A new study, published on the bioRxiv* preprint server, has focused on public clonotypes, i.e., clones found in multiple individuals, for the development of a novel reverse epitope discovery technique. This technique holds greater potential for population-wide applications.
Brown was diagnosed with COPD and emphysema, the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals. Like most COPD patients, Brown was given medication but told there was no cure. He was 58 years old.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced data with the EndoBarrier Gastrointestinal Liner at 12 months showing significant weight loss and cardiovascular and metabolic improvements in obese patients.
› Verified 6 days ago
| Entity Name | St Francis Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447605514 PECOS PAC ID: 7214821909 Enrollment ID: O20040212000408 |
News Archive
Shortages of medical supplies such as ventilators, face shields and masks has been a recurring problem during the COVID-19 pandemic and production has struggled to keep up.
A new study, published on the bioRxiv* preprint server, has focused on public clonotypes, i.e., clones found in multiple individuals, for the development of a novel reverse epitope discovery technique. This technique holds greater potential for population-wide applications.
Brown was diagnosed with COPD and emphysema, the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals. Like most COPD patients, Brown was given medication but told there was no cure. He was 58 years old.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced data with the EndoBarrier Gastrointestinal Liner at 12 months showing significant weight loss and cardiovascular and metabolic improvements in obese patients.
› Verified 6 days ago
| Entity Name | Perham Hospital District |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932113768 PECOS PAC ID: 2264327766 Enrollment ID: O20040216000182 |
News Archive
Shortages of medical supplies such as ventilators, face shields and masks has been a recurring problem during the COVID-19 pandemic and production has struggled to keep up.
A new study, published on the bioRxiv* preprint server, has focused on public clonotypes, i.e., clones found in multiple individuals, for the development of a novel reverse epitope discovery technique. This technique holds greater potential for population-wide applications.
Brown was diagnosed with COPD and emphysema, the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals. Like most COPD patients, Brown was given medication but told there was no cure. He was 58 years old.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced data with the EndoBarrier Gastrointestinal Liner at 12 months showing significant weight loss and cardiovascular and metabolic improvements in obese patients.
› Verified 6 days ago
| Entity Name | Astera Health |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1477545333 PECOS PAC ID: 2961395272 Enrollment ID: O20060504000722 |
News Archive
Shortages of medical supplies such as ventilators, face shields and masks has been a recurring problem during the COVID-19 pandemic and production has struggled to keep up.
A new study, published on the bioRxiv* preprint server, has focused on public clonotypes, i.e., clones found in multiple individuals, for the development of a novel reverse epitope discovery technique. This technique holds greater potential for population-wide applications.
Brown was diagnosed with COPD and emphysema, the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals. Like most COPD patients, Brown was given medication but told there was no cure. He was 58 years old.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced data with the EndoBarrier Gastrointestinal Liner at 12 months showing significant weight loss and cardiovascular and metabolic improvements in obese patients.
› Verified 6 days ago
| Entity Name | Ccm Health |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1720086028 PECOS PAC ID: 4284539453 Enrollment ID: O20060504000810 |
News Archive
Shortages of medical supplies such as ventilators, face shields and masks has been a recurring problem during the COVID-19 pandemic and production has struggled to keep up.
A new study, published on the bioRxiv* preprint server, has focused on public clonotypes, i.e., clones found in multiple individuals, for the development of a novel reverse epitope discovery technique. This technique holds greater potential for population-wide applications.
Brown was diagnosed with COPD and emphysema, the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals. Like most COPD patients, Brown was given medication but told there was no cure. He was 58 years old.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced data with the EndoBarrier Gastrointestinal Liner at 12 months showing significant weight loss and cardiovascular and metabolic improvements in obese patients.
› Verified 6 days ago
| Entity Name | Centracare Health System - Melrose |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1720045073 PECOS PAC ID: 1658270368 Enrollment ID: O20060504000839 |
News Archive
Shortages of medical supplies such as ventilators, face shields and masks has been a recurring problem during the COVID-19 pandemic and production has struggled to keep up.
A new study, published on the bioRxiv* preprint server, has focused on public clonotypes, i.e., clones found in multiple individuals, for the development of a novel reverse epitope discovery technique. This technique holds greater potential for population-wide applications.
Brown was diagnosed with COPD and emphysema, the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals. Like most COPD patients, Brown was given medication but told there was no cure. He was 58 years old.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced data with the EndoBarrier Gastrointestinal Liner at 12 months showing significant weight loss and cardiovascular and metabolic improvements in obese patients.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Liban Farah, MD 1100 Bergslien St, Baldwin, WI 54002-2600 Ph: (715) 684-1111 | Dr Liban Farah, MD 1100 Bergslien St, Baldwin, WI 54002-2600 Ph: (715) 684-1111 |
News Archive
Shortages of medical supplies such as ventilators, face shields and masks has been a recurring problem during the COVID-19 pandemic and production has struggled to keep up.
A new study, published on the bioRxiv* preprint server, has focused on public clonotypes, i.e., clones found in multiple individuals, for the development of a novel reverse epitope discovery technique. This technique holds greater potential for population-wide applications.
Brown was diagnosed with COPD and emphysema, the third leading cause of death in the United States, only behind heart disease and cancer. Right now, the only studied interventions that prolong life for patients with severe COPD are supplemental oxygen in people with low oxygen levels and lung volume reduction surgery (LVRS) in appropriately selected individuals. Like most COPD patients, Brown was given medication but told there was no cure. He was 58 years old.
GI Dynamics, a leader in non-surgical, endoscopic treatments for type 2 diabetes and obesity, today announced data with the EndoBarrier Gastrointestinal Liner at 12 months showing significant weight loss and cardiovascular and metabolic improvements in obese patients.
› Verified 6 days ago
Thomas G Field, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Bergslien St, Baldwin, WI 54002 Phone: 715-684-1111 | |
Kaitlyn Sloan, APNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 660 Vandeberg St, Baldwin, WI 54002 Phone: 715-688-7411 | |
Shaima Sulemankhil, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 730 10th Ave., Baldwin, WI 54002 Phone: 715-684-3311 Fax: 715-684-4757 | |
Russell Roloff, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Bergslien St, Baldwin, WI 54002 Phone: 715-684-1111 Fax: 715-684-1119 | |
Clemma J Nash, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Bergslien St, Baldwin, WI 54002 Phone: 715-684-1111 Fax: 715-684-1119 | |
Brittany Beeson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Bergslien St, Baldwin, WI 54002 Phone: 715-684-1111 Fax: 715-684-1119 | |
Dr. Kathleen E Findlay, MD, MPH Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 Bergslien St, Baldwin, WI 54002 Phone: 715-684-1111 Fax: 715-684-1119 |